HeartPhone Cancer Survivors Trial 2019
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Leukemia|Lymphoma
Interventions: BEHAVIORAL: HeartPhone app|DRUG: Acetylcholine|DRUG: Sodium Nitroprusside|DRUG: L-Arginine, N2-((4-Methylphenyl)Sulfonyl)-, Methyl Ester
Sponsor: Penn State University